Alnylam Pharmaceuticals (ALNY) Return on Assets [ROA] (2010 - 2026)
Alnylam Pharmaceuticals' Return on Assets [ROA] was 14.50% in Q2 2026, up 21.01 percentage points from -6.51% a year earlier and up 3.84 percentage points from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Return on Assets [ROA] (2010 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Alnylam Pharmaceuticals came in at 6.82%, up 13.71 percentage points from FY2024.
- Return on Assets [ROA] has now increased for three consecutive years, with a five-year change of +36.40 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -6.89% in FY2024 (+5.04 pp), -11.94% in FY2023 (+19.53 pp), -31.47% in FY2022 (-7.27 pp) and -24.19% in FY2021 (+5.39 pp).
- The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] in data going back to Q3 2010.
- Compared with a year earlier, Return on Assets [ROA] has increased for four straight quarters, with an average year-over-year change of +8.77 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2024 (a gain of 29.44 percentage points); the worst was Q3 2022 (a drop of 10.43 percentage points).
- Per Business Quant data, ALNY's Return on Assets [ROA] in the three quarters before Q2 2026 was 10.66% (Q1 2026), 6.39% (Q4 2025) and 2.52% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 16.34% |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | 14.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.50% |
| Mar 31, 2026 | 10.66% |
| Dec 31, 2025 | 6.39% |
| Sep 30, 2025 | 2.52% |
| Jun 30, 2025 | -6.51% |
| Mar 31, 2025 | -5.45% |
| Dec 31, 2024 | -6.59% |
| Sep 30, 2024 | -8.09% |
| Jun 30, 2024 | -1.86% |
| Mar 31, 2024 | -8.68% |
| Dec 31, 2023 | -11.48% |
| Sep 30, 2023 | -14.08% |
| Jun 30, 2023 | -31.31% |
| Mar 31, 2023 | -30.70% |
| Dec 31, 2022 | -31.95% |
| Sep 30, 2022 | -34.44% |
| Jun 30, 2022 | -29.00% |
| Mar 31, 2022 | -25.23% |
| Dec 31, 2021 | -23.97% |
| Sep 30, 2021 | -24.00% |
API Access
Alnylam Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();